Entering text into the input field will update the search result below

Searching For A Bargain - Volume IV: Where Contrarians Look After A Monster Rally

Sep. 10, 2020 2:46 PM ETALACF, ALIAF, ASHR, EPI, EPOL, ERUS, EWG, EWI, EWL, EWN, EWO, EWP, EWS, EWY, EWZ, FUSB, FXF, FXI, GXC, INDA, INDY, IVV, MCHI, MJDLF, PIN, QQQ, RSX, RSXJ, SII, SMIN, SPY, VOO, VTI, MDI:CA, SII:CA4 Comments
Philip MacKellar profile picture
Philip MacKellar
755 Followers

Summary

  • 2020’s bipolar market action continues as new highs follow a record crash in the first half.
  • This article will review international market valuations versus valuations found on North American exchanges.
  • It will also discuss beaten-up American sectors, contrary Canadian opportunities, and general trends.

Introduction

Twice a year I conduct a screen of North American indexes, international benchmarks, and a top-to-bottom assessment of the existing watchlist here at Contra the Heard Investment Newsletter. This latest watchlist could not be more different than the one produced in March and April. At that time, the COVID-19 Coronavirus had altered the investment landscape significantly, with major global benchmarks falling into bear market territory. By contrast, markets are now back at record highs, and 2020 may go down as the year of the bipolar stock market.

As a result, the watchlist has contracted significantly. Today the list includes 607 US stocks, 117 Canadian names, and 29 ETFs. By contrast, the spring 2020 watchlist included 701 US names, 152 Canadian companies, and 42 ETFs. Those interested in the spring 2020 review can read about it here.

During this review process, I was repeatedly greeted by companies that had rallied, yet in many cases revenues were down significantly and profitability was gone. Moreover, a lot of companies I had been interested in during March have since taken on a lot more debt, and/or have seen insiders selling in droves. This cocktail of attributes explains why the watchlist and resulting shortlist is much smaller than it was six months ago.

The goal of this process is to identify opportunities worthy of further review, or companies which may make good portfolio additions in the coming months and years. After this review, 19 of the 635 US names fit into this category. In Canada, the shortlist is 6, with three ETFs high on the radar too.

Before reading further, keep in mind that I will not be discussing the individual names found during the process. Instead, this article will provide an overview of the countries and industries we are looking at closely.

International

This article was written by

Philip MacKellar profile picture
755 Followers
Philip MacKellar is an analyst, portfolio manager, and investor at Contra the Heard Investment Newsletter. He has been with the company since 2011 and has been investing since 2004. The newsletter’s primary focus is on contrarian and value-oriented investment opportunities traded in the United States and Canada. In addition, Philip sometimes engages in M&A, other special situations, and holds bonds, preferred shares, and convertible securities. Contra the Heard is a Toronto based company and was founded in 1995. Philip also blogs about personal finance topics on his own website called mymoneymoves.ca in his free time. You can also follow Philip at the Globe & Mail, on Twitter @Rallekcam, and catch him on YouTube at Contra the Heard.

Analyst’s Disclosure: I am/we are long MJDLF, ALIAF, SII, FUSB. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.